Health

The Health Policy Group provides policy analysis and innovative programming for state health policy leaders in the legislative and executive branches. This group also develops many publications and health forums for state leaders.

State leaders need access to critical and timely health policy information. CSG staff works to provide officials with best practices and policy analysis, helping lawmakers identify the best health solutions for their states.

CSG Midwest
Wisconsin Gov. Scott Walker signed 11 bills into law in July that seek to address myriad facets of the state’s opioid crisis. The bills were the product of a special session held earlier in the year.

Since 1999, the number of overdose deaths involving opioids (including prescription opioids and heroin) has quadrupled, accounting for six out of every 10 drug overdose deaths. Current estimates show that 91 Americans die each day from an opioid overdose, according to the Centers for Disease Control and Prevention, or CDC1.

Over the years, substance abuse trends in the states have shift from one drug to another as new policy solutions make previously abused drugs more scarce. Over the past decade, gabapentin has emerged as a drug of concern. Gabapentin, the generic for Neurontin, is a medication that was approved by the FDA in 1993 and is approved to treat epilepsy and nerve pain caused by shingles. The IMS Institute...

Drug abuse is an ever-growing epidemic in the United States. In a series of research briefs, CSG will examine the effects of drug abuse on the states through incarceration, treatment and the workforce.

The latest version of the Senate’s Better Care Reconciliation Act, or BCRA, was released July 20, 2017. According to the CBO analysis, the new version of the BCRA would reduce federal deficits by $420 billion over the 2017-2026 period, the net result of a direct spending decrease of $903 billion partially offset by a $483 billion decrease in revenues. Of special interest to states, the reduction in Medicaid spending is $772 billion, or 85 percent of the reduced spending, directly impacting states’ budgets. The effects of the bill on the number of uninsured is little changed from the earlier version. In 2018, 15 million more people would be uninsured than under current law and would reach 22 million in 2026.

On June 8, 2017, the Food and Drug Administration, or FDA, publicly requested that Endo Pharmaceuticals remove their drug, Opana ER, from the market. The agency stated that the benefits of the medication no longer outweighs the risks. According to the FDA, there has been a shift in abuse that has seen an increase in crushing, snorting and injecting the medication. This increase in injection abuse has also seen an increase in HIV and Hepatitis C...

The Centers for Disease Control and Prevention, or CDC, estimates that 91 Americans die each day from an opioid overdose. The opioid epidemic is one of the biggest public health challenges in the United States today, leading to higher drug abuse rates, increasing health care costs and imposing additional stress on state budgets. Three new reports released in June 2017 demonstrate the growing need for solutions.

Last week in Washington, D.C. 27 state legislative leaders gathered for the sixth annual CSG Medicaid 101 Policy Academy. Attention was focused on the Medicaid reform plan, called the Better Care Reconciliation Act of 2017, under consideration in the U.S. Senate following the House approval of the American Health Care Act in early May. CSG prepared a brief side-by-side comparison of the...

The stability of the individual health insurance market is on many policymakers’ minds as 2018 open enrollment for individual insurance purchased through the exchanges approaches. Participants in this webinar will have the opportunity to hear specifics regarding the cost of premiums in 2018, insurance issuer exits, and whether the Trump administration will continue to provide insurance companies with subsidies to offset the cost of lowering deductibles and other out of pocket costs for certain low-income consumers. This webinar will examine how the current climate surrounding the Affordable Care Act may affect the existing individual market.

Earlier this week, I spoke with Ohio Rep. Al Landis about a media campaign he has started to bring attention to the opioid crisis in his legislative district and spread a message about prevention. He calls it #gotyourback.  He asks people to post on his own personal Facebook page a picture of themselves back to back with a friend and the words “I’ve got your back! It’s what friends do. Help your friends say no to drugs.”

The campaign springs from his growing alarm about the opioid crisis in Ohio.

Pages